Page last updated: 2024-08-26

s-nitrosoglutathione and Hepatocellular Carcinoma

s-nitrosoglutathione has been researched along with Hepatocellular Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aranda, E; Corrales, FJ; López-Pedrera, C; López-Sánchez, LM; Rodríguez-Ariza, A1
Chih, TT; Chiu, HF; Hsian, YM; Tseng, CH; Wu, MJ; Wu, YC1
Calmels, S; Hainaut, P; Ohshima, H1

Other Studies

3 other study(ies) available for s-nitrosoglutathione and Hepatocellular Carcinoma

ArticleYear
Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells.
    Anticancer research, 2010, Volume: 30, Issue:2

    Topics: Antirheumatic Agents; Auranofin; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Nitrosation; Plicamycin; Proteins; Proteomics; S-Nitrosoglutathione; Spectrometry, Mass, Electrospray Ionization; Thioredoxin-Disulfide Reductase; Tumor Cells, Cultured

2010
Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.
    Biochemical pharmacology, 2003, Feb-01, Volume: 65, Issue:3

    Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Cyclic GMP; Drug Interactions; Fluorescein-5-isothiocyanate; Furans; Humans; S-Nitrosoglutathione; Tumor Cells, Cultured

2003
Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.
    Cancer research, 1997, Aug-15, Volume: 57, Issue:16

    Topics: Breast Neoplasms; Carcinoma, Hepatocellular; DNA, Neoplasm; Glutathione; Humans; Liver Neoplasms; Nitric Oxide; Nitroso Compounds; Penicillamine; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1997